Title of article
Hypertension in adult polycystic kidney disease: a narrative review
Author/Authors
Mian, Sarah Avalon University School of Medicine - Curacao, Netherlands Antilles , Acharya, Yogesh Avalon University School of Medicine - Curacao, Netherlands Antilles , Dahal, Ranjan Saint Peter’s University Hospital - New Jersey, USAID
Pages
5
From page
122
To page
126
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited renal disorder that impacts approximately 12 million worldwide. It is characterized by bilateral kidney enlargement and cystic growth. Hypertension (HTN) is a focal point in the management of ADPKD and is linked to a faster progression to end stage renal disease. Current novel therapies have proven to reduce the progression of renal damage. The ideal goal is to minimize risk through preventative studies and pharmacology to further increase life expectancy and quality. The purpose of this article is to highlight the importance of blood pressure management in ADPKD and review current literature to determine the most effective preventative pharmacotherapy.
Keywords
Adult polycystic kidney disease , Hypertension , Antihypertensive agents , Prevention and control , Renin–angiotensin–aldosterone system , End stage renal disease , Glomerular filtration rate , Chronic kidney disease
Journal title
Journal of Renal Injury Prevention
Serial Year
2019
Record number
2498148
Link To Document